– As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, we are delighted to announce the appointment of a neuroendocrine cancer Surgical Specialty Lead (SSL). This is the first time such a role has been established specifically for neuroendocrine...
The latest breakthrough in neuroendocrine cancer treatment comes from the NETTER-2 trial, where Lutetium (177Lu) oxodotreotide, a radio-labeled somatostatin analog, has shown remarkable success in treating high-grade advanced gastroenteropancreatic neuroendocrine...
– Mindfulness for Managing Pain, Anxiety and Fatigue In March 2023, our counselling and psychotherapy partners at RareMinds ran an Online (Zoom) taster session on ‘Mindfulness for Pain and Fatigue’ for our Neuroendocrine Cancer community. Following on from the...
PLEASE NOTE THAT THIS COURSE IS NOW FULLY BOOKED. – In 2023, we collaborated with our counseling and psychotherapy partners at RareMinds to host a successful Online (Zoom) 8-week ‘Living Well with…’ programme, tailored for those...
We’re thrilled to announce the return of our Natter support group meetings for 2024! Join us for the kickoff event, our first Webi-Natter, happening next Monday. – – 📅 Save the Date: – Date: Monday, 15th January 2024 – Time: 6:30 pm...
